Edwards Wildman Palmer LLP has hired Edward Glynn, a former senior official at the Federal Trade Commission.
Anishiya Abrol, a life sciences IP specialist, has been promoted to counsel at law firm Hogan Lovells.
EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner.
Enzo Biochem, a US biotechnology company, has received another $12.4 million from a patent ruling against Applera Corp, bringing the total damages sum to around $61 million.
IP litigator Thomas Wintner has been appointed partner at Edwards Wildman Palmer LLP.
Biopharmaceutical company AstraZeneca has paid $4.1 billion to acquire Bristol Myers Squibb’s share of the firms’ diabetes business venture.
Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets.
The US District Court for the District of Delaware has upheld the validity of a GSK-held patent that covers two HIV drugs marketed in the US by ViiV Healthcare.
Mylan Pharmaceuticals and its partner Banner Pharmacaps Inc, a subsidiary of Patheon Inc, have entered into a settlement and licence agreement with Japanese pharmaceutical company Eisai Inc and Valeant Pharmaceuticals Luxembourg S.a.r.l.
AstraZeneca has sued Aurobindo Pharma Limited and its US-based subsidiary Aurobindo Pharma USA Inc for infringing four of its patents related to heartburn drug Nexium.